{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:05:48Z","timestamp":1776279948819,"version":"3.50.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011744","name":"National University Health System","doi-asserted-by":"publisher","award":["NUHSRO\/2022\/063\/RO5+6\/Seed-Mar\/08"],"award-info":[{"award-number":["NUHSRO\/2022\/063\/RO5+6\/Seed-Mar\/08"]}],"id":[{"id":"10.13039\/501100011744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001413-00"],"award-info":[{"award-number":["MOH-001413-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["M23M6c0111"],"award-info":[{"award-number":["M23M6c0111"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04065-2","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T14:03:48Z","timestamp":1772287428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioorthogonal catalytic centres engineered for gastrointestinal stabilization provide oral delivery for the treatment of gastric cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Muthu Kumaraswamy","family":"Shanmugam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Vallerinteavide Mavelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pang","family":"Yuze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hrucha Shielesh","family":"Damle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leroy Sivappiragasam","family":"Pakkiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lik Hang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lim Poh","family":"Leong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhesh Sujit","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester Lee","family":"Drum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"issue":"16","key":"4065_CR1","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","volume":"29","author":"WJ Yang","year":"2023","unstructured":"Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29(16):2452\u201368.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"4065_CR2","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1245\/s10434-018-6627-y","volume":"25","author":"J Asplund","year":"2018","unstructured":"Asplund J, Kauppila JH, Mattsson F, Lagergren J. Survival trends in gastric adenocarcinoma: a population-based study in Sweden. Ann Surg Oncol. 2018;25(9):2693\u2013702.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4065_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63812-3","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang X, Chen YC, Yao M, Xiong R, Liu B, Zhu X, et al. Potential therapeutic targets of gastric cancer explored under endogenous network modeling of clinical data. Sci Rep. 2024;14(1):13127.","journal-title":"Sci Rep"},{"key":"4065_CR4","first-page":"277","volume":"400","author":"C Figueiredo","year":"2017","unstructured":"Figueiredo C, Camargo MC, Leite M, Fuentes-Panana EM, Rabkin CS, Machado JC. Pathogenesis of gastric cancer: genetics and molecular classification. Curr Top Microbiol Immunol. 2017;400:277\u2013304.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"17","key":"4065_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16172948","volume":"16","author":"M Inoue","year":"2024","unstructured":"Inoue M. Epidemiology of gastric cancer-changing trends and global disparities. Cancers (Basel). 2024;16(17):2948.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4065_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030543","volume":"10","author":"S Choi","year":"2022","unstructured":"Choi S, Park S, Kim H, Kang SY, Ahn S, Kim KM. Gastric cancer: mechanisms, biomarkers, and therapeutic approaches. Biomedicines. 2022;10(3):543.","journal-title":"Biomedicines"},{"issue":"1","key":"4065_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00565-1","volume":"12","author":"K Zhu","year":"2024","unstructured":"Zhu K, Yang X, Tai H, Zhong X, Luo T, Zheng H. HER2-targeted therapies in cancer: a systematic review. Biomark Res. 2024;12(1):16.","journal-title":"Biomark Res"},{"issue":"20","key":"4065_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205075","volume":"15","author":"T Baccili Cury Megid","year":"2023","unstructured":"Baccili Cury Megid T, Farooq AR, Wang X, Elimova E. Gastric cancer: molecular mechanisms, novel targets, and immunotherapies: from bench to clinical therapeutics. Cancers (Basel). 2023;15(20):5075.","journal-title":"Cancers (Basel)"},{"key":"4065_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00193","volume":"7","author":"Y Yao","year":"2020","unstructured":"Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci. 2020;7:193.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"4065_CR10","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","volume":"39","author":"RE Sexton","year":"2020","unstructured":"Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179\u2013203.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"4065_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2013.04.020","volume":"170","author":"K Thanki","year":"2013","unstructured":"Thanki K, Gangwal RP, Sangamwar AT, Jain S. Oral delivery of anticancer drugs: challenges and opportunities. J Control Release. 2013;170(1):15\u201340.","journal-title":"J Control Release"},{"issue":"3","key":"4065_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","volume":"11","author":"B Homayun","year":"2019","unstructured":"Homayun B, Lin X, Choi HJ. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 2019;11(3):129.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4065_CR13","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1080\/10717544.2018.1501119","volume":"25","author":"J Reinholz","year":"2018","unstructured":"Reinholz J, Landfester K, Mailander V. The challenges of oral drug delivery via nanocarriers. Drug Deliv. 2018;25(1):1694\u2013705.","journal-title":"Drug Deliv"},{"issue":"4","key":"4065_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s12276-023-00960-y","volume":"55","author":"C Song","year":"2023","unstructured":"Song C, Chai Z, Chen S, Zhang H, Zhang X, Zhou Y. Intestinal mucus components and secretion mechanisms: what we do and do not know. Exp Mol Med. 2023;55(4):681\u201391.","journal-title":"Exp Mol Med"},{"issue":"2","key":"4065_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/138920010791110836","volume":"11","author":"Z Cai","year":"2010","unstructured":"Cai Z, Wang Y, Zhu LJ, Liu ZQ. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr Drug Metab. 2010;11(2):197\u2013207.","journal-title":"Curr Drug Metab"},{"key":"4065_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jconrel.2016.06.016","volume":"240","author":"AA Date","year":"2016","unstructured":"Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: design, evaluation and state-of-the-art. J Control Release. 2016;240:504\u201326.","journal-title":"J Control Release"},{"issue":"7","key":"4065_CR17","doi-asserted-by":"publisher","first-page":"10292","DOI":"10.1021\/acsnano.1c11560","volume":"16","author":"S Sadeghi","year":"2022","unstructured":"Sadeghi S, Masurkar ND, Vallerinteavide Mavelli G, Deshpande S, Kok Yong Tan W, Yee S, et al. Bioorthogonal catalysis for treatment of solid tumors using thermostable, self-assembling, single enzyme nanoparticles and natural product conversion with indole-3-acetic acid. ACS Nano. 2022;16(7):10292\u2013301.","journal-title":"ACS Nano"},{"issue":"12","key":"4065_CR18","doi-asserted-by":"publisher","first-page":"8228","DOI":"10.1021\/jacs.3c13165","volume":"146","author":"Q Wang","year":"2024","unstructured":"Wang Q, Li X, Cao Z, Feng W, Chen Y, Jiang D. Enzyme-mediated bioorthogonal cascade catalytic reaction for metabolism intervention and enhanced ferroptosis on neuroblastoma. J Am Chem Soc. 2024;146(12):8228\u201341.","journal-title":"J Am Chem Soc"},{"issue":"8","key":"4065_CR19","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1021\/acsabm.0c00581","volume":"3","author":"Y Liu","year":"2020","unstructured":"Liu Y, Bai Y. Design and engineering of metal catalysts for bio-orthogonal catalysis in living systems. ACS Appl Bio Mater. 2020;3(8):4717\u201346.","journal-title":"ACS Appl Bio Mater"},{"issue":"11","key":"4065_CR20","first-page":"3314","volume":"7","author":"G Xu","year":"2001","unstructured":"Xu G, McLeod HL. Strategies for enzyme\/prodrug cancer therapy. Clin Cancer Res. 2001;7(11):3314\u201324.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4065_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/pharmaceutics15020484","volume":"15","author":"J Lou","year":"2023","unstructured":"Lou J, Duan H, Qin Q, Teng Z, Gan F, Zhou X, et al. Advances in oral drug delivery systems: challenges and opportunities. Pharmaceutics. 2023;15(2):484.","journal-title":"Pharmaceutics"},{"issue":"6","key":"4065_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40262-013-0040-2","volume":"52","author":"FE Stuurman","year":"2013","unstructured":"Stuurman FE, Nuijen B, Beijnen JH, Schellens JH. Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement. Clin Pharmacokinet. 2013;52(6):399\u2013414.","journal-title":"Clin Pharmacokinet"},{"issue":"17","key":"4065_CR23","doi-asserted-by":"publisher","first-page":"9856","DOI":"10.3390\/ijms23179856","volume":"23","author":"S Sadeghi","year":"2022","unstructured":"Sadeghi S, Vallerinteavide Mavelli G, Vaidya SS, Drum CL. Gastrointestinal Tract Stabilized Protein Delivery Using Disulfide Thermostable Exoshell System. Int J Mol Sci. 2022;23(17):9856.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4065_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.str.2005.01.019","volume":"13","author":"E Johnson","year":"2005","unstructured":"Johnson E, Cascio D, Sawaya MR, Gingery M, Schroder I. Crystal structures of a tetrahedral open pore ferritin from the hyperthermophilic archaeon archaeoglobus fulgidus. Structure. 2005;13(4):637\u201348.","journal-title":"Structure"},{"issue":"1","key":"4065_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01585-2","volume":"8","author":"S Deshpande","year":"2017","unstructured":"Deshpande S, Masurkar ND, Girish VM, Desai M, Chakraborty G, Chan JM, et al. Thermostable exoshells fold and stabilize recombinant proteins. Nat Commun. 2017;8(1):1442.","journal-title":"Nat Commun"},{"issue":"1","key":"4065_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25996-4","volume":"12","author":"S Sadeghi","year":"2021","unstructured":"Sadeghi S, Deshpande S, Vallerinteavide Mavelli G, Aksoyoglu A, Bafna J, Winterhalter M, et al. A general approach to protein folding using thermostable exoshells. Nat Commun. 2021;12(1):5720.","journal-title":"Nat Commun"},{"issue":"2","key":"4065_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.sjbs.2018.04.002","volume":"26","author":"M Saud Al-Bagmi","year":"2019","unstructured":"Saud Al-Bagmi M, Shahnawaz Khan M, Alhasan Ismael M, Al-Senaidy AM, Ben Bacha A, Mabood Husain F, et al. An efficient methodology for the purification of date palm peroxidase: stability comparison with horseradish peroxidase (HRP). Saudi J Biol Sci. 2019;26(2):301\u20137.","journal-title":"Saudi J Biol Sci"},{"issue":"27","key":"4065_CR28","doi-asserted-by":"publisher","first-page":"13957","DOI":"10.1021\/acs.langmuir.4c01180","volume":"40","author":"FE Breausche","year":"2024","unstructured":"Breausche FE, Somerlot A, Walder J, Osei K, Okyem S, Driskell JD. Immobilization of thiol-modified horseradish peroxidase on gold nanoparticles enhances enzyme stability and prevents proteolytic digestion. Langmuir. 2024;40(27):13957\u201367.","journal-title":"Langmuir"},{"key":"4065_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-pathol-052016-100247","volume":"12","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Kepp O, Chan FK, Kroemer G. Necroptosis: mechanisms and relevance to disease. Annu Rev Pathol. 2017;12:103\u201330.","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"4065_CR30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18(5):1106\u201321.","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"4065_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrm3683","volume":"14","author":"D Ofengeim","year":"2013","unstructured":"Ofengeim D, Yuan J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol. 2013;14(11):727\u201336.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7516","key":"4065_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature13608","volume":"513","author":"M Dannappel","year":"2014","unstructured":"Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature. 2014;513(7516):90\u20134.","journal-title":"Nature"},{"issue":"339","key":"4065_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad3099","volume":"8","author":"G Brumatti","year":"2016","unstructured":"Brumatti G, Ma C, Lalaoui N, Nguyen NY, Navarro M, Tanzer MC, et al. The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia. Sci Transl Med. 2016;8(339):339ra69.","journal-title":"Sci Transl Med"},{"key":"4065_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1446486","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, He H, Qu L, Shen Q, Dai Y. Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis. Front Pharmacol. 2024;15:1446486.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4065_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41419-023-05691-6","volume":"14","author":"K Ye","year":"2023","unstructured":"Ye K, Chen Z, Xu Y. The double-edged functions of necroptosis. Cell Death Dis. 2023;14(2):163.","journal-title":"Cell Death Dis"},{"issue":"7","key":"4065_CR36","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1016\/S0021-9258(18)34832-4","volume":"257","author":"PD Josephy","year":"1982","unstructured":"Josephy PD, Eling T, Mason RP. The horseradish peroxidase-catalyzed oxidation of 3,5,3\u2019,5\u2019-tetramethylbenzidine. Free radical and charge-transfer complex intermediates. J Biol Chem. 1982;257(7):3669\u201375.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"4065_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1\u20132):55\u201363.","journal-title":"J Immunol Methods"},{"issue":"3","key":"4065_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.bbrc.2011.06.186","volume":"411","author":"H Sawai","year":"2011","unstructured":"Sawai H, Domae N. Discrimination between primary necrosis and apoptosis by necrostatin-1 in annexin V-positive\/propidium iodide-negative cells. Biochem Biophys Res Commun. 2011;411(3):569\u201373.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7950","key":"4065_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","volume":"615","author":"J Tintelnot","year":"2023","unstructured":"Tintelnot J, Xu Y, Lesker TR, Schonlein M, Konczalla L, Giannou AD, et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature. 2023;615(7950):168\u201374.","journal-title":"Nature"},{"key":"4065_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-1050-2_3","volume":"1180","author":"AT Feldman","year":"2014","unstructured":"Feldman AT, Wolfe D. Tissue processing and hematoxylin and eosin staining. Methods Mol Biol. 2014;1180:31\u201343.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"4065_CR41","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1101\/pdb.prot073411","volume":"2014","author":"RD Cardiff","year":"2014","unstructured":"Cardiff RD, Miller CH, Munn RJ. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc. 2014;2014(6):655\u20138.","journal-title":"Cold Spring Harb Protoc"},{"issue":"6","key":"4065_CR42","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.jaci.2022.07.025","volume":"150","author":"SH Tay","year":"2022","unstructured":"Tay SH, Santosa A, Goh ECH, Xu CX, Wu LH, Bigliardi-Qi M, et al. Distinct transcriptomic and metabolomic profiles characterize NSAID-induced urticaria\/angioedema patients undergoing aspirin desensitization. J Allergy Clin Immunol. 2022;150(6):1486\u201397.","journal-title":"J Allergy Clin Immunol"},{"key":"4065_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1033083","volume":"9","author":"ML Ng","year":"2022","unstructured":"Ng ML, Kuan WS, Pakkiri LS, Goh ECH, Wu LH, Drum CL. Deep phenotyping of oxidative stress in emergency room patients reveals homoarginine as a novel predictor of sepsis severity, length of hospital stay, and length of intensive care unit stay. Front Med (Lausanne). 2022;9:1033083.","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"4065_CR44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nprot.2011.319","volume":"6","author":"J Xia","year":"2011","unstructured":"Xia J, Wishart DS. Web-based inference of biological patterns, functions and pathways from metabolomic data using metaboanalyst. Nat Protoc. 2011;6(6):743\u201360.","journal-title":"Nat Protoc"},{"issue":"12","key":"4065_CR45","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/acs.molpharmaceut.7b00426","volume":"14","author":"B Hens","year":"2017","unstructured":"Hens B, Tsume Y, Bermejo M, Paixao P, Koenigsknecht MJ, Baker JR, et al. Low buffer capacity and alternating motility along the human gastrointestinal tract: implications for in vivo dissolution and absorption of ionizable drugs. Mol Pharm. 2017;14(12):4281\u201394.","journal-title":"Mol Pharm"},{"key":"4065_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.biomaterials.2016.05.006","volume":"98","author":"L Li","year":"2016","unstructured":"Li L, Munoz-Culla M, Carmona U, Lopez MP, Yang F, Trigueros C, et al. Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells. Biomaterials. 2016;98:143\u201351.","journal-title":"Biomaterials"},{"issue":"1","key":"4065_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53943-3","volume":"9","author":"L Stuhn","year":"2019","unstructured":"Stuhn L, Auernhammer J, Dietz C. pH-depended protein shell dis- and reassembly of ferritin nanoparticles revealed by atomic force microscopy. Sci Rep. 2019;9(1):17755.","journal-title":"Sci Rep"},{"issue":"33","key":"4065_CR48","doi-asserted-by":"publisher","first-page":"18562","DOI":"10.1039\/D0CP02069A","volume":"22","author":"B Maity","year":"2020","unstructured":"Maity B, Li Z, Niwase K, Ganser C, Furuta T, Uchihashi T, et al. Single-molecule level dynamic observation of disassembly of the apo-ferritin cage in solution. Phys Chem Chem Phys. 2020;22(33):18562\u201372.","journal-title":"Phys Chem Chem Phys"},{"issue":"6","key":"4065_CR49","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1021\/acs.nanolett.9b01148","volume":"19","author":"S Chakraborti","year":"2019","unstructured":"Chakraborti S, Korpi A, Kumar M, Stepien P, Kostiainen MA, Heddle JG. Three-dimensional protein cage array capable of active enzyme capture and artificial chaperone activity. Nano Lett. 2019;19(6):3918\u201324.","journal-title":"Nano Lett"},{"issue":"47","key":"4065_CR50","doi-asserted-by":"publisher","first-page":"14933","DOI":"10.1002\/anie.201708530","volume":"56","author":"S Tetter","year":"2017","unstructured":"Tetter S, Hilvert D. Enzyme encapsulation by a ferritin cage. Angew Chem Int Ed Engl. 2017;56(47):14933\u20136.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4065_CR51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/CMAR.S149619","volume":"10","author":"R Sitarz","year":"2018","unstructured":"Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239\u201348.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"4065_CR52","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10120-023-01373-6","volume":"26","author":"T Sato","year":"2023","unstructured":"Sato T, Saito M, Nakajima S, Saito K, Katagata M, Fukai S, et al. ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer. Gastric Cancer. 2023;26(3):379\u201392.","journal-title":"Gastric Cancer"},{"issue":"4","key":"4065_CR53","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0006-2952(98)00323-2","volume":"57","author":"LK Folkes","year":"1999","unstructured":"Folkes LK, Dennis MF, Stratford MR, Candeias LP, Wardman P. Peroxidase-catalyzed effects of indole-3-acetic acid and analogues on lipid membranes, DNA, and mammalian cells in vitro. Biochem Pharmacol. 1999;57(4):375\u201382.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"4065_CR54","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0006-2952(00)00498-6","volume":"61","author":"LK Folkes","year":"2001","unstructured":"Folkes LK, Wardman P. Oxidative activation of indole-3-acetic acids to cytotoxic species- a potential new role for plant auxins in cancer therapy. Biochem Pharmacol. 2001;61(2):129\u201336.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"4065_CR55","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.trecan.2017.03.002","volume":"3","author":"A Najafov","year":"2017","unstructured":"Najafov A, Chen H, Yuan J. Necroptosis and cancer. Trends Cancer. 2017;3(4):294\u2013301.","journal-title":"Trends Cancer"},{"key":"4065_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105297","volume":"163","author":"L Cao","year":"2021","unstructured":"Cao L, Mu W. Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharmacol Res. 2021;163:105297.","journal-title":"Pharmacol Res"},{"issue":"1\u20132","key":"4065_CR57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10495-023-01905-6","volume":"29","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Cai Z, Zhai Y, Yu J, He Q, He Y, et al. Necroptosis inhibitors: mechanisms of action and therapeutic potential. Apoptosis. 2024;29(1\u20132):22\u201344.","journal-title":"Apoptosis"},{"issue":"3","key":"4065_CR58","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.str.2013.01.016","volume":"21","author":"T Xie","year":"2013","unstructured":"Xie T, Peng W, Liu Y, Yan C, Maki J, Degterev A, et al. Structural basis of RIP1 inhibition by necrostatins. Structure. 2013;21(3):493\u20139.","journal-title":"Structure"},{"issue":"6","key":"4065_CR59","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1038\/cddis.2012.64","volume":"3","author":"DE Christofferson","year":"2012","unstructured":"Christofferson DE, Li Y, Hitomi J, Zhou W, Upperman C, Zhu H, et al. A novel role for RIP1 kinase in mediating TNFalpha production. Cell Death Dis. 2012;3(6):e320.","journal-title":"Cell Death Dis"},{"issue":"5","key":"4065_CR60","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/10715769509065262","volume":"23","author":"LP Candeias","year":"1995","unstructured":"Candeias LP, Folkes LK, Porssa M, Parrick J, Wardman P. Enhancement of lipid peroxidation by indole-3-acetic acid and derivatives: substituent effects. Free Radic Res. 1995;23(5):403\u201318.","journal-title":"Free Radic Res"},{"issue":"1","key":"4065_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0898-6568(03)00091-3","volume":"16","author":"DS Kim","year":"2004","unstructured":"Kim DS, Jeon SE, Park KC. Oxidation of indole-3-acetic acid by horseradish peroxidase induces apoptosis in G361 human melanoma cells. Cell Signal. 2004;16(1):81\u20138.","journal-title":"Cell Signal"},{"key":"4065_CR62","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"4065_CR63","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017;482(3):419\u201325.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4065_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.548","volume":"6","author":"S Saveljeva","year":"2015","unstructured":"Saveljeva S, Mc Laughlin SL, Vandenabeele P, Samali A, Bertrand MJ. Endoplasmic reticulum stress induces ligand-independent TNFR1-mediated necroptosis in L929 cells. Cell Death Dis. 2015;6(1):e1587.","journal-title":"Cell Death Dis"},{"issue":"10","key":"4065_CR65","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1194\/jlr.M700389-JLR200","volume":"49","author":"CH Jakobsen","year":"2008","unstructured":"Jakobsen CH, Storvold GL, Bremseth H, Follestad T, Sand K, Mack M, et al. DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis. J Lipid Res. 2008;49(10):2089\u2013100.","journal-title":"J Lipid Res"},{"issue":"4","key":"4065_CR66","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s11064-008-9882-7","volume":"34","author":"J Long","year":"2009","unstructured":"Long J, Liu C, Sun L, Gao H, Liu J. Neuronal mitochondrial toxicity of malondialdehyde: inhibitory effects on respiratory function and enzyme activities in rat brain mitochondria. Neurochem Res. 2009;34(4):786\u201394.","journal-title":"Neurochem Res"},{"issue":"1","key":"4065_CR67","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejphar.2010.09.033","volume":"650","author":"J Cheng","year":"2011","unstructured":"Cheng J, Wang F, Yu DF, Wu PF, Chen JG. The cytotoxic mechanism of malondialdehyde and protective effect of carnosine via protein cross-linking\/mitochondrial dysfunction\/reactive oxygen species\/MAPK pathway in neurons. Eur J Pharmacol. 2011;650(1):184\u201394.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"4065_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119534","volume":"1870","author":"C Horvath","year":"2023","unstructured":"Horvath C, Jarabicova I, Kura B, Kalocayova B, Faurobert E, Davidson SM, et al. Novel, non-conventional pathways of necroptosis in the heart and other organs: molecular mechanisms, regulation and inter-organelle interplay. Biochim Biophys Acta Mol Cell Res. 2023;1870(7):119534.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"4","key":"4065_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100814","volume":"2","author":"K Li","year":"2021","unstructured":"Li K, Wang A, Liu H, Li B. Protocol for chemically induced murine gastric tumor model. STAR Protoc. 2021;2(4):100814.","journal-title":"STAR Protoc"},{"issue":"3","key":"4065_CR70","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4251\/wjgo.v16.i3.979","volume":"16","author":"YM Wang","year":"2024","unstructured":"Wang YM, Luo ZW, Shu YL, Zhou X, Wang LQ, Liang CH, et al. Effects of Helicobacter pylori and Moluodan on the Wnt\/beta-catenin signaling pathway in mice with precancerous gastric cancer lesions. World J Gastrointest Oncol. 2024;16(3):979\u201390.","journal-title":"World J Gastrointest Oncol"},{"key":"4065_CR71","volume":"2022","author":"SX Zhang","year":"2022","unstructured":"Zhang SX, Tian W, Liu YL, Ni JH, Zhang D, Pan HF, et al. Mechanism of N-methyl-N-nitroso-urea-induced gastric precancerous lesions in mice. J Oncol. 2022;2022:3780854.","journal-title":"J Oncol"},{"issue":"4","key":"4065_CR72","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00403-009-0938-6","volume":"301","author":"SY Kim","year":"2009","unstructured":"Kim SY, Kim MK, Kwon SB, Na JI, Park KC, Kim DS. Tumor apoptosis by indole-3-acetic acid\/light in B16F10 melanoma-implanted nude mice. Arch Dermatol Res. 2009;301(4):319\u201322.","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"4065_CR73","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41416-020-01156-1","volume":"124","author":"VDB Bonifacio","year":"2021","unstructured":"Bonifacio VDB, Pereira SA, Serpa J, Vicente JB. Cysteine metabolic circuitries: druggable targets in cancer. Br J Cancer. 2021;124(5):862\u201379.","journal-title":"Br J Cancer"},{"issue":"1","key":"4065_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01581-0","volume":"9","author":"S Shen","year":"2023","unstructured":"Shen S, Shao Y, Li C. Different types of cell death and their shift in shaping disease. Cell Death Discov. 2023;9(1):284.","journal-title":"Cell Death Discov"},{"issue":"3","key":"4065_CR75","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25(3):486\u2013541.","journal-title":"Cell Death Differ"},{"issue":"5","key":"4065_CR76","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/carcin\/bgw032","volume":"37","author":"KD McCormick","year":"2016","unstructured":"McCormick KD, Ghosh A, Trivedi S, Wang L, Coyne CB, Ferris RL, et al. Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinoma. Carcinogenesis. 2016;37(5):522\u20139.","journal-title":"Carcinogenesis"},{"issue":"1","key":"4065_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2016.06.002","volume":"30","author":"U Hockendorf","year":"2016","unstructured":"Hockendorf U, Yabal M, Herold T, Munkhbaatar E, Rott S, Jilg S, et al. RIPK3 restricts myeloid leukemogenesis by promoting cell death and differentiation of leukemia initiating cells. Cancer Cell. 2016;30(1):75\u201391.","journal-title":"Cancer Cell"},{"issue":"4","key":"4065_CR78","doi-asserted-by":"publisher","first-page":"592","DOI":"10.4149\/neo_2015_071","volume":"62","author":"X Feng","year":"2015","unstructured":"Feng X, Song Q, Yu A, Tang H, Peng Z, Wang X. Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer. Neoplasma. 2015;62(4):592\u2013601.","journal-title":"Neoplasma"},{"issue":"10","key":"4065_CR79","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1007\/s13277-016-5229-1","volume":"37","author":"Z Ertao","year":"2016","unstructured":"Ertao Z, Jianhui C, Kang W, Zhijun Y, Hui W, Chuangqi C, et al. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric Caner. Tumour Biol. 2016;37(10):13679\u201385.","journal-title":"Tumour Biol"},{"issue":"2","key":"4065_CR80","doi-asserted-by":"publisher","first-page":"e1636","DOI":"10.1038\/cddis.2015.16","volume":"6","author":"K Moriwaki","year":"2015","unstructured":"Moriwaki K, Bertin J, Gough PJ, Orlowski GM, Chan FK. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death. Cell Death Dis. 2015;6(2):e1636.","journal-title":"Cell Death Dis"},{"issue":"9","key":"4065_CR81","doi-asserted-by":"publisher","first-page":"e1884","DOI":"10.1038\/cddis.2015.240","volume":"6","author":"P Geserick","year":"2015","unstructured":"Geserick P, Wang J, Schilling R, Horn S, Harris PA, Bertin J, et al. Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death Dis. 2015;6(9):e1884.","journal-title":"Cell Death Dis"},{"issue":"10","key":"4065_CR82","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13(10):714\u201326.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4065_CR83","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1158\/1535-7163.MCT-06-0511","volume":"6","author":"W Han","year":"2007","unstructured":"Han W, Li L, Qiu S, Lu Q, Pan Q, Gu Y, et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther. 2007;6(5):1641\u20139.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"4065_CR84","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.immuni.2014.09.016","volume":"41","author":"K Moriwaki","year":"2014","unstructured":"Moriwaki K, Balaji S, McQuade T, Malhotra N, Kang J, Chan FK. The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. Immunity. 2014;41(4):567\u201378.","journal-title":"Immunity"},{"key":"4065_CR85","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcdb.2014.07.003","volume":"35","author":"JV Lu","year":"2014","unstructured":"Lu JV, Chen HC, Walsh CM. Necroptotic signaling in adaptive and innate immunity. Semin Cell Dev Biol. 2014;35:33\u20139.","journal-title":"Semin Cell Dev Biol"},{"issue":"6258","key":"4065_CR86","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.aad0395","volume":"350","author":"N Yatim","year":"2015","unstructured":"Yatim N, Jusforgues-Saklani H, Orozco S, Schulz O, Barreira da Silva R, Reis e Sousa C, et al. RIPK1 and NF-kappaB signaling in dying cells determines cross-priming of CD8(+) T cells. Science. 2015;350(6258):328\u201334.","journal-title":"Science"},{"key":"4065_CR87","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.semcdb.2014.07.002","volume":"35","author":"S Fulda","year":"2014","unstructured":"Fulda S. Therapeutic exploitation of necroptosis for cancer therapy. Semin Cell Dev Biol. 2014;35:51\u20136.","journal-title":"Semin Cell Dev Biol"},{"issue":"5","key":"4065_CR88","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/cdd.2016.8","volume":"23","author":"Z Su","year":"2016","unstructured":"Su Z, Yang Z, Xie L, DeWitt JP, Chen Y. Cancer therapy in the necroptosis era. Cell Death Differ. 2016;23(5):748\u201356.","journal-title":"Cell Death Differ"},{"issue":"15","key":"4065_CR89","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1002\/chem.202003927","volume":"27","author":"P Destito","year":"2021","unstructured":"Destito P, Vidal C, Lopez F, Mascarenas JL. Transition metal-promoted reactions in aqueous media and biological settings. Chemistry. 2021;27(15):4789\u2013816.","journal-title":"Chemistry"},{"issue":"5","key":"4065_CR90","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1039\/C7CS00447H","volume":"47","author":"Y Bai","year":"2018","unstructured":"Bai Y, Chen J, Zimmerman SC. Designed transition metal catalysts for intracellular organic synthesis. Chem Soc Rev. 2018;47(5):1811\u201321.","journal-title":"Chem Soc Rev"},{"issue":"11","key":"4065_CR91","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.3390\/pharmaceutics13111790","volume":"13","author":"G Vallerinteavide Mavelli","year":"2021","unstructured":"Vallerinteavide Mavelli G, Sadeghi S, Vaidya SS, Kong SN, Drum CL. Nanoencapsulation as a general solution for lyophilization of labile substrates. Pharmaceutics. 2021;13(11):1790.","journal-title":"Pharmaceutics"},{"issue":"10","key":"4065_CR92","doi-asserted-by":"publisher","first-page":"e109062","DOI":"10.1371\/journal.pone.0109062","volume":"9","author":"L Navapour","year":"2014","unstructured":"Navapour L, Mogharrab N, Amininasab M. How modification of accessible lysines to phenylalanine modulates the structural and functional properties of horseradish peroxidase: a simulation study. PLoS One. 2014;9(10):e109062.","journal-title":"PLoS One"},{"issue":"4","key":"4065_CR93","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/pharmaceutics17040397","volume":"17","author":"KC Baral","year":"2025","unstructured":"Baral KC, Choi KY. Barriers and strategies for oral peptide and protein therapeutics delivery: update on clinical advances. Pharmaceutics. 2025;17(4):397.","journal-title":"Pharmaceutics"},{"key":"4065_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2023.102848","volume":"313","author":"H Spleis","year":"2023","unstructured":"Spleis H, Sandmeier M, Claus V, Bernkop-Schnurch A. Surface design of nanocarriers: key to more efficient oral drug delivery systems. Adv Colloid Interface Sci. 2023;313:102848.","journal-title":"Adv Colloid Interface Sci"},{"key":"4065_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2024.103322","volume":"334","author":"B Hazt","year":"2024","unstructured":"Hazt B, Read DJ, Harlen OG, Poon WCK, O\u2019Connell A, Sarkar A. Mucoadhesion across scales: towards the design of protein-based adhesives. Adv Colloid Interface Sci. 2024;334:103322.","journal-title":"Adv Colloid Interface Sci"},{"issue":"1","key":"4065_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01539-x","volume":"20","author":"DA Subramanian","year":"2022","unstructured":"Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnology. 2022;20(1):362.","journal-title":"J Nanobiotechnology"},{"issue":"6","key":"4065_CR97","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1021\/jacsau.1c00128","volume":"1","author":"Q Laurent","year":"2021","unstructured":"Laurent Q, Martinent R, Lim B, Pham AT, Kato T, Lopez-Andarias J, et al. Thiol-mediated uptake. JACS Au. 2021;1(6):710\u201328.","journal-title":"JACS Au"},{"issue":"3","key":"4065_CR98","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbagen.2011.07.016","volume":"1820","author":"TR Daniels","year":"2012","unstructured":"Daniels TR, Bernabeu E, Rodriguez JA, Patel S, Kozman M, Chiappetta DA, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta. 2012;1820(3):291\u2013317.","journal-title":"Biochim Biophys Acta"},{"key":"4065_CR99","doi-asserted-by":"publisher","first-page":"4257342","DOI":"10.1155\/2022\/4257342","volume":"2022","author":"J Cao","year":"2022","unstructured":"Cao J, Hu C, Xu J, Han J, Zhang R, Cao M, et al. Aberrant expression TFR1\/CD71 in gastric cancer identifies a novel potential prognostic marker and therapeutic target. Evid Based Complement Alternat Med. 2022;2022:4257342.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"44","key":"4065_CR100","doi-asserted-by":"publisher","first-page":"29893","DOI":"10.1021\/acsomega.1c04382","volume":"6","author":"MS Lodhi","year":"2021","unstructured":"Lodhi MS, Khan MT, Bukhari SMH, Sabir SH, Samra ZQ, Butt H, et al. Probing transferrin receptor overexpression in gastric cancer mice models. ACS Omega. 2021;6(44):29893\u2013904.","journal-title":"ACS Omega"},{"issue":"37","key":"4065_CR101","doi-asserted-by":"publisher","first-page":"11714","DOI":"10.1073\/pnas.1511701112","volume":"112","author":"AC Chen","year":"2015","unstructured":"Chen AC, Donovan A, Ned-Sykes R, Andrews NC. Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis. Proc Natl Acad Sci U S A. 2015;112(37):11714\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"4065_CR102","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/sj.cgt.7700258","volume":"7","author":"O Greco","year":"2000","unstructured":"Greco O, Folkes LK, Wardman P, Tozer GM, Dachs GU. Development of a novel enzyme\/prodrug combination for gene therapy of cancer: horseradish peroxidase\/indole-3-acetic acid. Cancer Gene Ther. 2000;7(11):1414\u201320.","journal-title":"Cancer Gene Ther"},{"issue":"9","key":"4065_CR103","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.4161\/cc.4.9.1993","volume":"4","author":"BB Aggarwal","year":"2005","unstructured":"Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle. 2005;4(9):1201\u201315.","journal-title":"Cell Cycle"},{"issue":"1","key":"4065_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03031-4","volume":"23","author":"OD Reyes-Hernandez","year":"2023","unstructured":"Reyes-Hernandez OD, Figueroa-Gonzalez G, Quintas-Granados LI, Gutierrez-Ruiz SC, Hernandez-Parra H, Romero-Montero A, et al. 3,3\u2019-diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways. Cancer Cell Int. 2023;23(1):180.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4065_CR105","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13045-022-01350-z","volume":"15","author":"R Qin","year":"2022","unstructured":"Qin R, You FM, Zhao Q, Xie X, Peng C, Zhan G, et al. Naturally derived Indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. J Hematol Oncol. 2022;15(1):133.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"4065_CR106","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3892\/etm.2014.1696","volume":"8","author":"CG Mao","year":"2014","unstructured":"Mao CG, Tao ZZ, Chen Z, Chen C, Chen SM, Wan LJ. Indole-3-carbinol inhibits nasopharyngeal carcinoma cell growth in vivo and in vitro through inhibition of the PI3K\/Akt pathway. Exp Ther Med. 2014;8(1):207\u201312.","journal-title":"Exp Ther Med"},{"issue":"1","key":"4065_CR107","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jss.2016.04.021","volume":"204","author":"BW Megna","year":"2016","unstructured":"Megna BW, Carney PR, Nukaya M, Geiger P, Kennedy GD. Indole-3-carbinol induces tumor cell death: function follows form. J Surg Res. 2016;204(1):47\u201354.","journal-title":"J Surg Res"},{"issue":"2","key":"4065_CR108","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage Aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39(2):372\u201385.","journal-title":"Immunity"},{"issue":"1","key":"4065_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0296-x","volume":"8","author":"LS Zhang","year":"2016","unstructured":"Zhang LS, Davies SS. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med. 2016;8(1):46.","journal-title":"Genome Med"},{"issue":"12","key":"4065_CR110","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3109\/13880209.2014.902082","volume":"52","author":"Y Kamisah","year":"2014","unstructured":"Kamisah Y, Qodriyah HM, Chua KH, Nur Azlina MF. Vitamin E: a potential therapy for gastric mucosal injury. Pharm Biol. 2014;52(12):1591\u20137.","journal-title":"Pharm Biol"},{"issue":"9","key":"4065_CR111","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/nu11092062","volume":"11","author":"Y Ji","year":"2019","unstructured":"Ji Y, Gao Y, Chen H, Yin Y, Zhang W. Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress. Nutrients. 2019;11(9):2062.","journal-title":"Nutrients"},{"issue":"10","key":"4065_CR112","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s12276-022-00859-0","volume":"54","author":"NK Lee","year":"2022","unstructured":"Lee NK, Cho S, Kim IS. Ferritin - a multifaceted protein scaffold for biotherapeutics. Exp Mol Med. 2022;54(10):1652\u20137.","journal-title":"Exp Mol Med"},{"issue":"Pt 2","key":"4065_CR113","doi-asserted-by":"publisher","first-page":"134373","DOI":"10.1016\/j.ijbiomac.2024.134373","volume":"277","author":"R Lucignano","year":"2024","unstructured":"Lucignano R, Sanita G, Esposito E, Russo Krauss I, D\u2019Ursi AM, Buonocore M, et al. Human ferritin nanocarriers for drug-delivery: A molecular view of the disassembly process. Int J Biol Macromol. 2024;277(Pt 2):134373.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"4065_CR114","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.canlet.2008.01.033","volume":"262","author":"JR Weng","year":"2008","unstructured":"Weng JR, Tsai CH, Kulp SK, Chen CS. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett. 2008;262(2):153\u201363.","journal-title":"Cancer Lett"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04065-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:01:55Z","timestamp":1776276115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04065-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4065"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04065-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experiments involving animals were conducted according to the ethical policies and procedures reviewed and approved by the ethics committee of the National University of Singapore, Institutional Animal Care and Use Committee, Singapore (IACUC Protocol No. R22-1119).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}